The Effect of Radiotherapy Assisted Targeted Therapy on the Efficacy, Immune Function and Quality of Life of Patients with Non Small Cell Lung Cancer
Download as PDF
Ming Luo, Xing Ming, Chunli Chen, Zhiguo Luo
Objective: To explore the effect of radiotherapy assisted targeted therapy on the efficacy, immune function and quality of life of patients with non-small cell lung cancer. Methods: a total of 100 patients with NSCLC admitted to our hospital from March 2018 to July 2019 were randomly divided into two groups each with 50 people: the observation group (radiotherapy assisted targeted therapy) and the control group (conventional radiotherapy and chemotherapy combined therapy). Results: compared with the control group (62%), the total effective rate of the observation group (82%) was higher (P < 0.05); after treatment, the CD3 +, CD4 +, CD4 + / CD8 + of the observation group was higher than that of the control group, and CD8 + was lower than that of the control group (P < 0.05); and the scores of each index of quality of life were higher (P < 0.05). Conclusion: After the radiotherapy assisted targeted therapy for patients with NSCLC, it can improve the therapeutic effect, enhance the cellular immune function and improve the quality of life of patients with NSCLC.
Radiotherapy assisted targeted therapy, Non-small cell lung cancer, Clinical efficacy, Immune function, Quality of life